Key result
Transcatheter dilatation serves as a therapeutic option for treating critical aortic valve stenosis in critically ill newborn infants.
Answers are grounded in this paper and cite their sources.
This review addresses important clinical issues regarding transcatheter dilatation as a therapeutic option for critical aortic valve stenosis in newborn infants.
Critical aortic valve stenosis is not a frequently seen disease. In most cases, these patients are in critical condition. Transcatheter dilatation is one of the therapeutic options for treatment. This article addresses important issues in transcatheter dilatation in the newborn infant.
No takes yet. Share an insight, caveat, or question.
JEAN‐FRANÇOIS PIÉCHAUD (2001) studied this question. Transcatheter dilatation serves as a therapeutic option for treating critical aortic valve stenosis in critically ill newborn infants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: